$271 Million is the total value of Artia Global Partners LP's 36 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 30.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVO | Sell | NOVO-NORDISK A Sadr | $51,092,693 | +1.7% | 321,055 | -13.5% | 18.88% | -1.3% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $16,135,263 | -17.3% | 88,831 | -10.5% | 5.96% | -19.8% |
| ARGX | Sell | ARGENX SEsponsored adr | $13,563,402 | -58.0% | 36,404 | -57.3% | 5.01% | -59.3% |
| ISEE | Sell | IVERIC BIO INC | $9,844,283 | -8.9% | 404,615 | -19.8% | 3.64% | -11.6% |
| LLY | Sell | LILLY ELI & CO | $9,247,614 | -75.8% | 26,928 | -74.2% | 3.42% | -76.5% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $1,138,993 | -7.4% | 68,408 | -47.7% | 0.42% | -10.2% |
| Sell | AMYLYX PHARMACEUTICALS INC | $244,666 | -72.3% | 8,339 | -65.1% | 0.09% | -73.2% | |
| KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.28% | – |
| Exit | MODERNA INCcall | $0 | – | -10,000 | -100.0% | -0.68% | – | |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -22,321 | -100.0% | -0.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NOVO-NORDISK A S | 4 | Q3 2023 | 25.8% |
| MERCK & CO INC | 4 | Q3 2023 | 14.1% |
| ARGENX SE | 4 | Q3 2023 | 12.3% |
| LILLY ELI & CO | 4 | Q3 2023 | 14.5% |
| ABBVIE INC | 4 | Q3 2023 | 5.6% |
| ASTRAZENECA PLC | 4 | Q3 2023 | 5.4% |
| SEAGEN INC | 4 | Q3 2023 | 4.5% |
| BIOMARIN PHARMACEUTICAL INC | 4 | Q3 2023 | 4.3% |
| NEUROCRINE BIOSCIENCES INC | 4 | Q3 2023 | 2.1% |
| VERTEX PHARMACEUTICALS INC | 4 | Q3 2023 | 2.6% |
View Artia Global Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View Artia Global Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.